曲美他嗪治疗老年性缺血性心脏病心力衰竭的临床疗效

Curative effect of Trimetazidine dihydroch/ozide Tablets(VASoREL) on senile ischemic heart disease and heart failure

目的:观察曲美他嗪治疗老年性缺血性心脏病心力衰竭的疗效。方法:对我院107例缺血性心脏病心力衰竭患者在常规治疗基础上应用曲美他嗪进行治疗。结果:经过治疗患者所有指标均有显著改善,与治疗前比较,差异有统计学意义(P<0.05),其中显效75例(70.1%),有效28例(26.2%),无效4例(3.7%),总有效率为96.3%,无明显不良反应。结论:在常规治疗基础上,应用曲美他嗪治疗老年性缺血性心脏病心力衰竭疗效确切,心脏功能明显改善,临床耐受性好。

Objective ：To observe the effects of Trimetazidine dihydroch/ozide Tablets （VASorel） on Senile ischemic heart dis- ease？ and Heart failure, nethods：107 patients were selected with ischemic heart disease and Heart failure, who, while treated with Conventional treatment, were administered taking Trimetazidine dihydroch/ozide Tablets. Results： After the treatment, indices of pa- tients were improved evidently. Comparing with before treatment, the difference was statistically significant （p 〈 0.05）. Among 107 patients, 75 （70.1% ） were Significant effective, 28 （26.2%） were effective, 4 （3.7 % ） were ineffective. The total effective rate was 96.3%, with no significant adverse reactions. Conclusions： while treated with Conventional treatment, taking additional Trimetazidine dihydroch/ozide Tablets （VASoREL） significantly improved Curative effect on Senile ischemic heart disease and Heart failure, with good clinical tolerability.